Literature DB >> 20005932

The freeze-thawed and freeze-dried stability of cytarabine-encapsulated multivesicular liposomes.

Chengjun Chen1, Dandan Han, Yu Zhang, Yue Yuan, Xing Tang.   

Abstract

To investigate the stability of cytarabine-encapsulated multivesicular liposomes (MVLs) following freeze-thawing/freeze-drying, three types of phospholipids (EPC, DPPC, and DOPC) were separately employed to prepare MVLs using a double emulsification method. The cytarabine retention (CR), phase transition behavior, aggregation/rupture of vesicles and particle size were monitored using HPLC, differential scanning calorimetry (DSC), digital biological microscopy and a laser diffraction particle size analyzer. The effect of trehalose, the lipid bilayer composition and triglyceride on the drug retention was also investigated. The DPPC-MVLs and EPC-MVLs achieved the best protective effect during freeze-thawing and freeze-drying, respectively, while DOPC-MVLs produced the lowest drug retention during both procedures. Digital biological microscopy showed that most of the MVLs were divided into small irregular and regular vesicles after freeze-thawing and freeze-drying, which was in agreement with the reduction in particle size. The vesicle fragmentations may result from the splitting of triglyceride from the lipid membrane or rupture of the lipid membrane. The rehydrated EPC-MVLs still displayed a controlled-release profile in vitro, and the results presented in this work should help in stabilizing hydrophilic drug-encapsulated liposomes with a large particle size. 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20005932     DOI: 10.1016/j.ijpharm.2009.12.017

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  3 in total

1.  Optimization on Preparation Conditions of Salidroside Liposome and Its Immunological Activity on PCV-2 in Mice.

Authors:  Yibo Feng; Xiaojuan Zhao; Fang Lv; Jinqiu Zhang; Bihua Deng; Yanhong Zhao; Yuanliang Hu; Deyun Wang; Jiaguo Liu; Yu Lu; Ruonan Bo; Zhenguang Liu
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-23       Impact factor: 2.629

2.  Cerebrospinal Fluid Drug Concentrations and Clinical Outcome of Patients with Neoplastic Meningitis Treated with Liposomal Cytarabine.

Authors:  Jan-Paul Bohn; Vera Reinstadler; Georg Pall; Günther Stockhammer; Michael Steurer; Herbert Oberacher; Dominik Wolf
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2019-12       Impact factor: 2.441

3.  Liposomal remdesivir inhalation solution for targeted lung delivery as a novel therapeutic approach for COVID-19.

Authors:  Jingjing Li; Kai Zhang; Di Wu; Lianjie Ren; Xinyu Chu; Chao Qin; Xiaopeng Han; Taijun Hang; Yungen Xu; Lei Yang; Lifang Yin
Journal:  Asian J Pharm Sci       Date:  2021-10-21       Impact factor: 6.598

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.